The QualityStocks Daily Wednesday, January 11th, 2023

Today's Top 3 Investment Newsletters

Wall St. Warrior(BBBY) $3.4900 +68.60%

The Stock Dork(LASE) $3.5000 +38.34%

MarketClub Analysis(HEPA) $0.6220 +35.42%

The QualityStocks Daily Stock List

BioRestorative Therapies, Inc. (BRTX)

QualityStocks, MarketBeat, AwesomeStocks, TradersPro, PoliticsAndMyPortfolio, Streetwise Reports, ProActive Capital and Investor Ideas reported earlier on BioRestorative Therapies, Inc. (BRTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioRestorative Therapies, Inc. is a life sciences company focusing on adult stem cell-based therapies for various personal medical applications. The Company develops products and medical procedures utilizing cell and tissue protocols, primarily involving adult stem cells. OTCQB-listed, BioRestorative Therapies has its corporate, administrative, and laboratory operations in Melville, New York.

The Company’s aim is to become a leader in providing medical procedures using cell and tissue protocols, chiefly involving adult stem cells (non-embryonic), and enabling patients to undergo minimally invasive cellular-based treatments. BioRestorative Therapies is developing a cell-based therapy to target obesity and metabolic disorders utilizing brown adipose (fat) derived stem cells to produce brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. 

Bio Restorative’s lead cell therapy candidate is BRTX 100. This product is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. The Company’s products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and ThermoStem®, its Metabolic Program.

brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™’s intention is for patients who have failed non-invasive procedures and face the prospect of surgery. ThermoStem® is a treatment using brown fat stem cells. ThermoStem® is under development for metabolic disorders, including diabetes and obesity.

BioRestorative Therapies is also the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.

BioRestorative Therapies, Inc. (BRTX), closed Wednesday's trading session at $3.18, up 0.955586%, on 3,633 volume. The average volume for the last 3 months is 312,680 and the stock's 52-week low/high is $2.46/$5.975.

CVD Equipment (CVV)

Wall Street Resources, MarketBeat, TradersPro, StreetInsider, QualityStocks, CRWEFinance, Streetwise Reports, DrStockPick,, PennyToBuck, CRWEPicks, CRWEWallStreet, MarketClub Analysis, PennyOmega, SmarTrend Newsletters, StockHotTips, Outsider Club, Market Wrap Daily, BestOtc, TradingMarkets, TopStockAnalysts, The Street, Street Insider, Greenbackers, Zacks, StockMarketWatch, OTC Markets Group, Barchart, SmallCapVoice and FeedBlitz reported earlier on CVD Equipment (CVV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CVD Equipment Corporation (NASDAQ: CVV) (FRA: 0V3) is focused on designing, developing, manufacturing and selling process equipment and solutions which are utilized in the development and manufacture of coatings and materials for industrial and research applications.

The firm has its headquarters in Central Islip, New York and was incorporated in 1982, on October 13th by Leonard A. Rosenbaum. The firm serves consumers in the United States as well as internationally.

The company operates through the CVD Materials, SDC, Corporate and CVD segments. The corporate segment refers to the company’s administration activities which include anti-corrosion, customer support and process software services while the CVD materials segment provides material coatings for electronic, medical and aerospace applications. The SDC segment comprises of its ultra-high purity manufacturing division while the CVD segment is used for chemical vapor deposition equipment manufacturing. The company serves the solar photovoltaics, semiconductor, optoelectronics, nanomaterials, military, medical, glass coatings and aerospace markets.

The enterprise provides custom and standard fabricated quartz-ware used in various tools as well as its equipment. It also offers replacement and repair services for existing quartz-ware. In addition to this, the enterprise provides rapid thermal processing systems used in silicide formation. It also avails chemical vapor deposition systems which are utilized in researching, developing and manufacturing solar cells, carbon nanotubes and nanowires.

The company recently received a huge order from a major electric car battery material manufacturer in the U.S. With electric vehicle sales projected to grow significantly in the coming years, this contract will be helpful in extending the firm’s consumer reach in the sector and will also help bring in more opportunities and investments into the firm, which will have a positive effect on the company’s growth.

CVD Equipment (CVV), closed Wednesday's trading session at $7.7, up 22.2222%, on 312,680 volume. The average volume for the last 3 months is 66.308M and the stock's 52-week low/high is $3.68/$8.1999.

Broadwind Inc. (BWEN)

SmarTrend Newsletters, Alternative Energy, The Street, QualityStocks, StockEgg, BullRally, HotOTC, StreetAuthority Daily, OTCtipReporter, MarketBeat, StockMarketWatch, CRWEWallStreet, StreetInsider, CoolPennyStocks, TradersPro, DrStockPick, PennyStockScholar, PennyStockVille, InvestorPlace, MadPennyStocks, CRWEPicks, CRWEFinance, MarketClub Analysis, BestOtc, PennyOmega, FeedBlitz, StockRich, StockOodles, StockHotTips, PennyInvest, PennyToBuck, Investor Update, Daily Trade Alert, Stock Traders Chat, Stock Rich, Stock News Now, PennyTrader Publisher, MicrocapVoice, Zacks, Greenbackers, TraderPower, TopStockAnalysts, BUYINS.NET, The Wealth Report, The Wall Street Transcript, The Online Investor, Penny Invest, Stock Fortune Teller, FNNO Newsletters, Green Chip Stocks, PubCo Journal, SmallCapVoice,, Jason Bond, and PhD-Trading reported earlier on Broadwind Inc. (BWEN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Broadwind, Inc. (NASDAQ: BWEN) (FRA: 9IRA) provides wind energy equipment. The company offers turbines, gearboxes, and process systems, as well as assembling, testing, machining, and other related services. The firm mainly serves customers in the United States. The company was formerly known as Broadwind Energy, Inc. and changed its name to Broadwind, Inc. in May 2020. It is headquartered in Cicero, Illinois.

The firm, founded in 1996, is engaged in the manufacture of structures, equipment, and components for clean tech and other specialized applications. It operates through the following business segments: Heavy Fabrications, Gearing, and Industrial Solutions segments. The heavy fabrications segment provides fabrication services to customers in industrial markets. The gearing segment provides gearing and gearboxes to customers in diverse markets including onshore and offshore O&G fracking and drilling, surface and underground mining, wind energy, steel, material handling and other industrial markets. The industrial solutions segment provides supply chain solutions, inventory management, kitting and assembly services primarily serving the combined cycle natural gas turbine market.

The company manufactures towers for wind turbines, specifically the large and heavier wind towers that are designed for multiple megawatt wind turbines. It also builds and remanufactures precision gears and gearing systems for oil and gas, wind energy, mining, steel and other industrial applications, as well as providing contract manufacturing services throughout the U.S. and internationally, primarily supporting the natural gas turbine power generation market.

With the shift to renewable energy in order to tame the escalating climate change and global warming, Broadwind is bound to be even more attractive to investors, and this will boost its growth further.

Broadwind Inc. (BWEN), closed Wednesday's trading session at $4.45, up 96.9027%, on 66,455,669 volume. The average volume for the last 3 months is 136,958 and the stock's 52-week low/high is $1.46/$5.00.

Journey Medical Corp. (DERM)

MarketClub Analysis, StreetInsider, MarketBeat, Schaeffer's, InvestorPlace, StockMarketWatch, Wealth Insider Alert, The Street, Barchart, Kiplinger Today, QualityStocks, BUYINS.NET, Daily Trade Alert, Trades Of The Day, TraderPower, Traders For Cash Flow, Short Term Wealth, InvestorsUnderground, FreeRealTime, The Online Investor, Daily Market Beat, The Stock Dork and reported earlier on Journey Medical Corp. (DERM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Journey Medical Corp. (NASDAQ: DERM) is a commercial-stage pharmaceutical firm that is focused on the development and commercialization of pharmaceutical products for treating various dermatological indications.

The firm has its headquarters in Scottsdale, Arizona and was incorporated in October 2014 by Claude Maraoui. Prior to its name change, the firm was known as Coronado Dermatology Inc. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has twenty-two companies in its corporate family and primarily serves consumers in the United States.

The company identifies, acquires, develops and strategically commercializes innovative, differentiated generic dermatology products via its efficient sales and marketing model. It operates as a subsidiary of Fortress Biotech Inc.

The enterprise’s product portfolio is comprised of 3 authorized generic prescription drugs and five branded generic drugs for dermatological conditions. Its marketed products include an oral isotretinoin drug known as Accutane, for the treatment of severe recalcitrant acne; a medicated cloth towelette dubbed Qbrexza, to treat primary auxiliary hyperhidrosis; an oral minocycline drug known as Ximino, developed to treat moderate to severe acne; an oral doxycycline drug dubbed Targadox, for adjunctive therapy for severe acne; and an Exelderm solution and cream for topical use. The enterprise’s authorized products include sulconazole nitrate cream, minocycline hydrochloride capsules and doxycycline hyclate tablets.

The firm, which recently listed on the NASDAQ, appointed a new Chief Financial Officer, which helps to strengthen its leadership team. It is currently focused on the development and advancement of its pipeline, which positions them for continued growth.

Journey Medical Corp. (DERM), closed Wednesday's trading session at $2.39, up 29.1892%, on 136,958 volume. The average volume for the last 3 months is 14,417 and the stock's 52-week low/high is $1.05/$6.1899.

Investcorp Credit Management (ICMB)

The Online Investor, StreetInsider, MarketBeat, TradersPro and Investors Alley reported earlier on Investcorp Credit Management (ICMB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Investcorp Credit Management BDC Inc. (NASDAQ: ICMB) is a business development firm operating as a closed-end investment fund that specializes in loan, middle market, mezzanine, acquisitions, growth capital, organic growth, market/product expansion, recapitalization investments and refinancings.

The firm has its headquarters in New York and was established in February 2012. It operates as part of the asset management industry, under the financial services sector. The firm serves consumers in the United States and Europe.

The company’s primary investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing directly in debt and related equity of privately held middle-market companies to help these companies fund acquisitions, growth or refinancing. Its investment advisor is CM Investment Partners LLC.

The enterprise selectively invests in mezzanine loans/structured equity and in the equity of portfolio firms through warrants and other instruments, in most cases taking such upside participation interests as part of a broader investment relationship. The fund typically invests in the United States and Europe. Within the United States, the fund seeks to invest in Midatlantic, Midwest, Northeast, Southeast, and West Coast regions. The fund primarily invests in cable and satellites; consumer services; healthcare equipment and services; industrials; information technology; telecommunication services; and utilities sectors. The fund seeks to invest between $5 million to $25 million in companies that have annual revenues of at least $50 million with EBITDA at least $15 million.

The firm, which recently announced its latest financial results, remains focused on making investments in new portfolio companies. This will help position the firm well in the industry and open it up to new growth and investment opportunities.

Investcorp Credit Management (ICMB), closed Wednesday's trading session at $3.81, up 2.973%, on 14,442 volume. The average volume for the last 3 months is 8,362 and the stock's 52-week low/high is $3.24/$5.72.

Siebert Financial (SIEB)

Wall Street Resources, StreetInsider, StockMarketWatch, Wall Street Mover, PoliticsAndMyPortfolio, TradersPro, TraderPower, The Online Investor, Stock Market Watch and Schaeffer's reported earlier on Siebert Financial (SIEB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Siebert Financial Corp. (NASDAQ: SIEB) is a holding firm involved in retail discount brokerage and investment advisory businesses.

The firm has its headquarters in New York and was incorporated in 1934. It operates as part of the capital markets industry, under the financial services sector. The firm serves consumers around the globe, with a focus on the United States.

The company primarily operates through its subsidiary, Mueril Siebert & Co. and conducts the following lines of business: Retail Brokerage Business, Insurance Services, Investment Advisory Services, Prime Brokerage Services and Robo-Advisory Technology Development. It was formerly a Kennedy Cabot Acquisition LLC subsidiary. The company has twelve branch offices in the U.S.

The enterprise provides discount brokerage services, including self-directed trading, wealth management, market making and fixed income investment, financial advice, stock borrow, securities lending, equity compensation plans, equity stock plan, and market making services; retail customer services; and independent retail execution services. It also provides self-directed retirement accounts, as well as lends customers a portion of the market value of marginable securities held in the customer's account. This is in addition to offering a data technology platform that provides services like email and messaging, business productivity tools, market data systems and third party trading systems, and customer relationship management systems. Furthermore, the enterprise provides a Robo-Advisor platform that offers clients automated wealth management solutions.

The company recently announced its latest financial results, with its CEO noting that they remained focused on executing on the company’s growth strategy. This will position the company well to capitalize on the evolving needs of its consumers.

Siebert Financial (SIEB), closed Wednesday's trading session at $1.36, off by 0.729927%, on 8,424 volume. The average volume for the last 3 months is 170,802 and the stock's 52-week low/high is $1.20/$2.5412.


MarketBeat and Schaeffer's reported earlier on SGHC Ltd (SGHC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SGHC Ltd (NYSE: SGHC) is an entertainment company that operates as an online sports betting and gaming operator offering gaming and betting solutions.

The firm has its headquarters in Saint Peter Port, Guernsey and was incorporated in 2014. It operates as part of the gambling industry, under the consumer cyclical sector. The firm, also known as Super Group Ltd, serves consumers around the globe.

The company is focused on providing customers with the most engaging entertainment possible, through its advanced data driven analytics. It operates through its subsidiaries, which include Pelion Holdings Limited (Pelion), Fengari Holdings Limited (Fengari) and Pindus Holdings Limited (Pindus).

The enterprise is focused on the delivery of a converged interactive gaming experience allowing customers to interact with its games under numerous brands on a variety of platforms. Its offerings include Betway and Spin. Betway is an online sports betting brand offering with a global footprint derived from licenses to operate throughout Europe, Africa and the Americas. The brand is sports-led but also provides casino games. Its Spin offering is a multi-brand online casino offering. It has a diverse portfolio of roughly twenty casino brands, which are designed to be culturally relevant across the globe to offer a range of casino products.

The firm recently completed its acquisition of Digital Gaming Corporation Ltd, which will expand its global footprint into the United States. This move will also allow it to further capitalize on growth opportunities, which will create value for the firm’s shareholders.

SGHC Ltd (SGHC), closed Wednesday's trading session at $3.17, up 2.9221%, on 197,310 volume. The average volume for the last 3 months is 5,023 and the stock's 52-week low/high is $2.57/$11.09.

NetSol Technologies (NTWK)

Wall Street Resources, QualityStocks, Greenbackers, TaglichBrothers, Momentum Traders, InvestorPlace, OTCJournal, 777 Stocks, StockEgg, MarketBeat, SeriousTraders, StockOodles, HotOTC, CoolPennyStocks, The Street, BullRally, StockMarketWatch, Stocktwiter, Hit and Run Candle Sticks, MadPennyStocks, Access Wallstreet, Penny Invest, Zacks, PennyTrader Publisher, RedChip, PennyInvest, FeedBlitz, The Momentum Traders Network, PennyStockVille, StockRich, OTCtipReporter,, StreetInsider, Stock Fortune Teller, PennyStockScholar, CRWEPicks, MicrocapVoice, Breaking Bulls, CRWEWallStreet, Mad Stock Pic, M2 Communications, BUYINS.NET, Investing Futures, DrStockPick, GorillaTrades, CRWEFinance, StockHotTips, UrPicks, Trading Markets, Trading Concepts, TradersPro, Top Online Stocks, StreetAuthority Daily, StockSpice, Penny Stock Rumble, Stockhouse, MarketClub Analysis, Stock Rich, SmallCapVoice, Red Chip, PennyToBuck, PennyOmega, OTCReporter, OTCPicks, OTC Journal and StocksEarning reported earlier on NetSol Technologies (NTWK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Netsol Technologies Inc. (NASDAQ: NTWK) (FRA: NS9B) is a company focused on designing, developing, marketing and exporting enterprise software solutions to the banking, automobile financing and leasing, and financial services industries globally.

The firm has its headquarters in Calabasas, California and was incorporated in 1995 by Salim Ullah Ghauri. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe.

The enterprise’s offerings include a suite of financial applications for businesses in the finance and leasing industry dubbed NFS Ascent. Its NFS Ascent constituent applications include a web-based application known as Omni Point of Sale; a web-based solution that could be used in conjunction with WFS or any third-party wholesale finance system dubbed the Dealer Auditor Access System; an application for managing and maintaining credit contracts known as the Contract Management System (CMS); and a system for automating and managing the lifecycle of wholesale finance dubbed the Wholesale Finance System. The enterprise also offers a white label platform, which includes Dealer/Admin Tool and Customer Portals dubbed the Otoz Platform; an API-based architecture known as the Otoz Ecosystem; and Otoz Digital Auto-Retail, a white-label SaaS platform. This is in addition to offering system integration, consulting, and information technology products and services. It serves Dow-Jones 30 Industrials, blue chip organizations, vehicle manufacturers, Fortune 500 manufacturers and financial institutions.

The company recently entered into a teaming agreement with Digital Intelligence Systes LLC. This will help grow NetSol’s presence in the U.S. while also opening the company up to new growth and investment opportunities.

NetSol Technologies (NTWK), closed Wednesday's trading session at $2.885, up 3.964%, on 5,250 volume. The average volume for the last 3 months is 25,370 and the stock's 52-week low/high is $2.64/$4.4299.

Snail Inc. (SNAL)

We reported earlier on Snail Inc. (SNAL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Snail Inc. (NASDAQ: SNAL) is a technology-based firm focused on the development, marketing, publishing and distribution of interactive digital entertainment for consumers worldwide.

The firm has its headquarters in Culver City, California and was incorporated in 2009 by Shi Hai. It operates as part of the electronic gaming and multimedia industry, under the communication services sector. The firm serves consumers around the globe.

The company publishes its games under several specialized brands through its 2 publishing labels; Snail Games USA and Wandering Wizard. Snail Games USA is a global developer and publisher of digital entertainment. The company operates as an Olive Wood Global Development Ltd subsidiary.

The enterprise provides games, content, and support for different platforms, including game consoles, personal computers, mobile phones, and tablets. Its portfolio of games include ARK: Survival Evolved, Last Oasis, Action-adventure survival game, Nomadic Survival MMO game, Expedition Agartha, PixARK, Outlaws of the Old West, Fear the Night, Atlas, ZCREW, Dark and Light, Wushu Chronicles, Wushu Chronicles 2, ARK: Genesis Part 2, ARK: Genesis Part 1, Aberration, ARK: Extinction, ARK: Scorched Earth, Shard of Faith and TEK Edition, Skyward, Survival Evolved Mobile, Heroes, Taichi Panda, Kingdom Warriors, Dragon Hunter, Survival Heroes and Age of Wushu Dynasty.

The firm recently announced its latest financial results, with its CEO noting that they remained focused on executing against its product roadmap to provide high-end entertainment experiences for consumers globally. This will help bolster the firm’s overall growth while also creating value for its shareholders.

Snail Inc. (SNAL), closed Wednesday's trading session at $1.49, up 2.0548%, on 25,371 volume. The average volume for the last 3 months is 13,677 and the stock's 52-week low/high is $1.26/$4.36.

DoubleDown Interactive Co. Ltd. (DDI)

InvestorBrandNetwork, QualityStocks, MarketBeat, Zacks, The Stock Dork and InvestorPlace reported earlier on DoubleDown Interactive Co. Ltd. (DDI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, has entered into a share purchase agreement outlining details for the acquisition of SuprNation AB. The agreement details an offer for cash consideration of approximately $35 million on a cash-free, debt-free basis; the offer will be subject to a final 2022 financial review. Based in Europe, SuprNation is an i-Gaming company that provides a range of casino gaming experiences. The all-cash acquisition is anticipated to close sometime in Q2 2023, subject to customary conditions. Following the completion of the acquisition, SuprNation will be a direct, wholly owned subsidiary of DoubleDown Interactive LLC. “We are pleased to announce the first acquisition since DoubleDown’s IPO that we believe complements our existing social casino franchise well and exposes DoubleDown to new growth markets,” said DoubleDown Interactive CEO In Keuk Kim in the press release. “The acquisition of SuprNation increases our presence in the European i-Gaming market with other geographies expected to be added over time. Their gaming titles and captivating gamification features have created a loyal customer base that we aim to grow while capturing synergy opportunities, including incorporating our deep online gaming experience. As we evaluate inorganic growth opportunities, we will continue to focus on gaming businesses that offer clear synergies with our existing strengths.”

To view the full press release, visit

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information about this company, please visit

DoubleDown Interactive Co. Ltd. (DDI), closed Wednesday's trading session at $9.48, up 7.3613%, on 13,678 volume. The average volume for the last 3 months is 15.982M and the stock's 52-week low/high is $8.00/$15.64.

Coinbase Global Inc. (COIN)

InvestorPlace, Prfmonline, Schaeffer's, The Street, Greenbackers, MarketClub Analysis, QualityStocks, Kiplinger Today, MarketBeat, OTCPicks, SmallCapVoice, Ceocast News, HotOTC, CoolPennyStocks, Daily Trade Alert, Investopedia, StockEgg, Trades Of The Day, Stock Stars, Penny Invest, The Online Investor, Stock Rich, StocksEarning, The Wealth Report, BestOtc, Top Pros' Top Picks, The Stock Psycho, Top Gun, StockHotTips, HotShotStocks, CNBC Breaking News, BullRally, MadPennyStocks, Wealth Daily, PennyInvest, PennyStockVille, Profit Confidential, Today's Financial News, FeedBlitz, Zacks, StockRich, PennyTrader Publisher, Stockpalooza, Pennybuster, Early Bird, Atomic Trades, Blaque Capital Stocks, BloomMoney, Eagle Financial Publications, Dynamic Wealth Report, CRWEWallStreet, Cabot Wealth, Round Up the Bulls, wyatt research newsletter, WiseAlerts, StockMister, Stock Traders Chat, Stock Fortune Teller, Penny Stock Finder, Standout Stocks, Energy and Capital, Penny Stock Rumble, AllPennyStocks, Momentum Traders, MicrocapVoice, Louis Navellier, Green Chip Stocks and Stock Analyzer reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The world’s leading cryptocurrency exchange, Binance, remains firmly at the helm, closing 2022 with a 66.7% command of the trading market, in comparison to 48.7% at the beginning of the year. In a report by CryptoCompare, Binance took 66.7% of the market trading pie as far as centralized crypto exchanges are concerned at the end of 2022, after the FTX collapse. FTX was the company’s greatest rival.

An analysis found that Binance’s market share rise emerged even as the platform experienced a 45% decline in its trading volume. OKX and Coinbase Global Inc. (NASDAQ: COIN) shared the trading floor at 8.58% (OKX) and 8.50% (Coinbase) with a $813 billion and $805 billion trading volume respectively.

The same analysis also reported on a total of 11 exchanges, including Binance, Bittrex, Bybit,, KuCoin, Coinbase, Kraken, Bitfinex and OKX, among others. Of the above, Bybit and Kucoin increased their trading volume last year. Bybit also experienced market share growth during 2022.

The bumper harvest by Binance can be pinned on industry consolidation even as volumes were trending downward and the exchanges were competing for the reduced volumes, said the report. Furthermore, Binance’s decision to scrap trading fees for BTC and ETH in 2022 was followed by a huge surge in trading volume. This made Binance exceed the gross total volumes for 13 other exchanges by mid-September. The exchanges included Coinbase, Huobi, FTX and others.

U.S. crypto exchange Coinbase emerged second best in market share size by the end of 2022, standing at 8.2% compared to 10.1% at the beginning of 2022. Coinbase was followed closely by OKX, whose market share stood at 5.9% in December compared to 10.7% at the beginning of 2022.

The report further stated that overall trading volume in 2022 for centralized exchanges dipped by 46.2%. Crashing crypto prices and the decreased industry volatility were some of the key factors affecting the spiraling of the trading numbers.

Some of the greatest signals depicting the lack of engagement in the market are the decline in stability as well as volatility. On Oct. 22, 2022, the interannual 30-day Bitcoin volatility dropped to 26.6%, the lowest since mid-2020, conveying the risk aversion sentiment within the market.

The report asserts that 2022 was a “transformational year” for the digital asset space with episodes such as the crash of FTX and terra highlighting the discrepancies within the industry. Additionally, such episodes denote benefits defi can bring onboard through transparent and seamless infrastructure.

Coinbase Global Inc. (COIN), closed Wednesday's trading session at $43.79, up 1.2954%, on 16,152,705 volume. The average volume for the last 3 months is 399,439 and the stock's 52-week low/high is $31.55/$246.27.

Royal Gold Inc. (RGLD)

TopStockAnalysts, Streetwise Reports, StreetAuthority Daily, InvestorPlace, TradingAuthority Daily, The Street, MarketBeat, Daily Wealth, Top Pros' Top Picks, StreetInsider, QualityStocks, Daily Trade Alert, SmarTrend Newsletters, TheStockAdvisor, All about trends, Energy and Capital, Zacks, Money Morning, MarketClub Analysis, The Growth Stock Wire, TheStockAdvisors, Trades Of The Day, Dividend Opportunities,, Wyatt Investment Research, Barchart, Wealth Daily, Uncommon Wisdom,, Investor Update, Daily Profit, Schaeffer's, Investment U, Money and Markets, National Inflation Association, Stockhouse, The Online Investor, Traders For Cash Flow, TradingMarkets, Trade of the Week, Forbes, Market Intelligence Center Alert, Outsider Club, Greenbackers, Weekly Wizards, Kiplinger Today, FNNO Newsletters, AllPennyStocks, Dynamic Wealth Report, GorillaTrades, Bourbon and Bayonets, BestChartNow, Wealth Insider Alert, ChartAdvisor,, Stocks That Move, Penny Stock Chaser, PowerRatings Stocks, Profits Run, Short Term Wealth, Stansberry Research, Hit and Run Candle Sticks, Market Authority, One Hot Stock, StocksEarning, Investopedia, The Best Newsletters, Investing Futures, Inside Investing Daily, Market Report and Market FN reported earlier on Royal Gold Inc. (RGLD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gold stocks seem poised for a powerful resurgence in 2023 after a relatively lackluster performance for most of 2022. Although gold prices began rising toward the end of the year, factors such as inflation coupled with a strong dollar and an increasingly tight monetary policy by the U.S. Federal Reserve eroded gold’s appeal as a safe haven metal and kept its prices down.

Early projections released toward the end of last year showed that the gold market had plenty of room for growth in 2023, especially if the federal reserve chose to stabilize benchmark interest rates or even reduce them.

Gold miner stocks started the year strongly enough to raise hopes that they will continue surging to new heights into the year. In fact, gold stocks are performing so well they are getting close to one of their best buy signals despite recently bottoming after investors exceedingly oversold their gold stocks.

Sentiment across the gold market has shifted to bullish as gold prices grew steadily toward the end of 2022 and the start of 2023. The GDX VanEck Gold Miners EFT, for instance, has proven to be the leading benchmark of gold stocks, increasing in price by 41.4% over the three-plus months since September 2022. And in spite of a significant upside breakout, the GDX has soared past its key 200-day moving average and is poised to reach a powerful Golden Cross buy signal in the next few weeks.

Analysts and industry insiders expect the upcoming year to be significantly bullish because golden crosses tend to be strong bullish after extremely oversold lows covering several years. When this happens, the market usually experiences strong accelerating uplegs, pushing gold prices higher with room for even higher growth.

On the other hand, lesser gold crosses are common in sideways-shifting consolidating markets that aren’t recovering from significant lows. This is extremely evident in the GDX, which saw its largest drop in mid-2022 as prices for its major gold stocks tanked. By late September, major gold stocks in the GDX EFT had dropped by 46.5% over five-plus months.

The GDX finally bottomed out at $21.87, a low it hadn’t seen in two and a half years since the lockdown in March 2020 triggered panic among stockholders. GDX’s major gold stocks had recovered relatively well by April 2022, rising by 41.4% in six-plus months amid a growing gold upleg. If the fed chooses to stabilize or lower benchmark interest rates in 2023, gold prices may rally even higher.

If this expected rally materializes, mining companies such as Royal Gold Inc. (NASDAQ: RGLD) could be set to offer exceptional shareholder value.

Royal Gold Inc. (RGLD), closed Wednesday's trading session at $124.43, off by 0.24052%, on 399,439 volume. The average volume for the last 3 months is 12,436 and the stock's 52-week low/high is $84.54/$147.70.

The QualityStocks Company Corner

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria has announced patent #3,093,414, its first patent inCanada, its 28th granted patent worldwide, and the first patentfrom its sixth patent family

This patent joins the ranks of previously issued patents inAustralia, India, Japan, and the EU, even as similar patentapplications for skin-based delivery of patented DehydraTECHformulations remain pending in many countries

In Lexaria’s 2018 study, DehydraTECH-processed CBD demonstratedalmost a 1,900% increase in CBD permeability through human skincompared to a control formulation that was devoid of any commercialpenetration enhancers

This patent inches Lexaria closer to taking advantage of thecosmeceuticals market, projected to hit $95.95 billion by 2030, andthe global skincare market that is estimated to post a CAGR of 4.6%over the forecast period (2021-2030)

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced its28th granted patent worldwide and the first granted patent from itssixth patent family, titled “Transdermal And/Or Dermal Delivery OfLipophilic Active Agents.” The Canadian patent #3,093,414 is forimproved compositions and methods for transdermal and dermaldelivery of cannabinoids, including cannabidiol (“CBD”) andtetrahydrocannabinol (“THC”), all established on the company’spatented DehydraTECH technology (

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Wednesday's trading session at $2.6499, up 1.9192%, on 12,438 volume. The average volume for the last 3 months is 199.992M and the stock's 52-week low/high is $1.80/$4.94.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Afeela, Honda and Sony worked together on a newly developed conceptelectric vehicle that was unveiled at the 2023 Sony CES conferenceheld in Las Vegas. The Afeela car will be able to stream movies andplay Playstation 5 games. After signing an MOU to strengthen relationships within the mobility sector in March2022, the joint venture, called Sony Honda Mobility, will createand develop a new electric vehicle named Afeela. Sony has continuedto support this mobility drive since the 2020 debut of the Vision-S car concept. Although the concept was never realized, Afeela appears to haveacquired Sony’s intentions to incorporate its many technologieseither on the inside or outside of the car. Leveraging Sony’ssensor expertise, the Afeela car concept has 45 cameras as well assensors placed inside and outside the car, including some that arein a position to sense the driver’s status along with the car’svisual condition to prevent accidents. The Qualcomm technology will be used where the latest chassis, the Snapdragon Digital Chassis, will be utilized in order to realize next-generation mobility. AsSony and Honda take auto electronics a notch higher, other playerssuch as Mullen Automotive Inc. (NASDAQ: MULN) will focus on their own unique selling points in order to keepmaking a mark on the market.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $0.3995, up 5.8559%, on 199,991,890 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.94/$.

Recent News

MetAlert Inc. (OTC: MLRT)

The QualityStocks Daily Newsletter would like to spotlight MetAlert Inc. (OTC: MLRT).

MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices andwearable technology products for remote patient monitoring, signeda Heads of Terms agreement with TrakTec outlining details about thepreviously announced acquisition. The agreement noted that MLRTwould acquire the location-awareness technology company in a cashand stock deal worth $4.5 million. The agreement also notes thatthe acquisition should be closed on or before March 17, 2023, andwill include TrakTec’s active paying subscriber base, policedepartment contracts, commercial ready tracking products, andbackend platform and mobile app. In addition, the agreement notedthat key hires would include board director, chief technologyofficer, head of marketing, and retired police chief and supportstaff. TrakTec, which offers affordable, scalablelocation-awareness technology solutions for consumer, enterprise,and government applications, operates iGPS Watches and SafetyNet(R) Tracking Systems that offer a range of enhancedmonitoring services. “We are extremely excited about theopportunity to acquire TrakTec,” said MetAlert CEO Patrick Bertagnain the press release. “We see a lot of synergy and complimentarytechnology that will not only fit right in with our existingsubscription business model but also help expand it. We expect togain several benefits including additional revenues, subscribers,GPS devices for kids, and an RFID-based tracking product that isapproved for federal grant funding, existing police contracts, andcertain key hires. Short-term, this will grow our existingsubscriber base, increase revenues and expand our product offering.Longer term, we will have more capability to develop new products,grow the government and police department sales channels, have asales and support presence on the East Coast, and accelerate thecompany’s growth as we work towards a possible 2023 uplist to anational exchange. There are several requirements to an uplist,such as having more independent directors, a stronger balancesheet, shareholder equity, etc., all of which this acquisition willhelp support.” To view the full article, visit Alzheimer’s is a debilitating mental illness that affects more than 6 million Americans of all ages. The condition is especially prevalent among theelderly, with an estimated 6.5 million Americans aged 65 and olderliving with Alzheimer’s last year. Some figures show that 73% of the people living with Alzheimer’s are 75 years old and older. Alzheimer’s usually occurs when amyloid proteins build up abnormally in and around brain cells and form deposits of plaque, causing a reduction inneurotransmitter activity. The plaque buildup causes parts of the brain to shrink over time, usually beginning with the regions in charge ofretaining memory. However, a new study from USC Leonard Davis School of Gerontology challenges thelong-thought notion that Alzheimer’s is caused by the buildup ofcertain proteins in the brain Although prior research hasassociated amyloid beta (Aβ) protein buildup with the developmentof Alzheimer’s, we don’t actually know what causes this buildup.The senior author of the study, Caleb Finch, who is also aprofessor at USC Leonard Davis, stated that little was alsoknown about the connection between this protein and normal brainaging. As researchers dig more into the reasons why Alzheimer’sdevelops and how it progresses, patients and their caregivers cancontinue to rely on the wearable devices made by manufacturers suchas MetAlert Inc. (OTC: MLRT) so that the effects of memory loss don’t result in somethingworse, such as a patient wandering away from home to an unsafeenvironment.

MetAlert Inc. (OTC: MLRT) is a pioneer in location sensitive health monitoring devices (estimated $47 billion industry in 2021) and wearable technology products (industry forecast to reach $174 billion by 2030).

With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leader for consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA). This market represents approximately 2.9% of the world’s population (approximately 34 million people in 24 developed countries). Due to specific behaviors (problems with memory, adversity to wearing unknown items, etc.) of consumers/patients in this market segment, traditional products, such as an iPhone or Fitbit, are not a practical solution. This has created a significant market with very few competitors for MetAlert.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, and selling products and services in GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. The company offers a global end-to-end hardware, software, and connectivity solution, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products and enterprise applications.

Using its award-winning, patented GPS SmartSole® as a hub for collecting and transmitting data to the cloud in real-time, MetAlert is expanding its value proposition to consumers and increasing its revenue per user (RPU) while creating the largest database of health statistics for ADA consumers/patients. MetAlert generates revenue from product sales, recurring subscriptions, intellectual property (IP) licensing, and professional services. The company has international distributors servicing customers in over 35 countries and is an approved U.S. military government contractor. Its customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers.

The company is headquartered in Los Angeles, California, with a sales office in London, England, and distributors across the globe.


  • GPS SmartSoles® HUB (launched Q4 2022) is a GPS/BLE-equipped insole that allows remote monitoring, data collection, and encrypted data transmission to the cloud.
    • Telehealth (available Q4 2022) allows access remotely to doctors and other health professionals on an as-needed basis. This service will also function as the prescribing doctor once Medicare reimbursement codes are established.
    • Concierge (available Q4 2022) provides 24/7/365 enhanced emergency response that coordinates with all relevant parties to quickly detect false alarms and escalate response as needed.
    • Bluetooth Enabled Devices (available Q1 2023) include third-party devices that collect vitals and other health data and connect with the GPS Smartsoles® HUB.
    • Artificial Intelligence (available Q1 2023) software will evaluate the Teradata of health information identifying trends and respond to preestablished alert thresholds.
  • Take-Along Tracker is a small GPS tracking device – less than three inches long – that works with 4G cellular service and will have the same “HUB” functionality as the GPS Smartsoles®. This versatile and affordable mini tracker boasts super long battery life, with up to 14 days of operation per charge.
  • RoomMate™ is a wall-mounted alert system that detects and alerts caregivers about patient behavior that could lead to falls and injuries. The system features 3D infrared and wall-mounted sensors, eliminating the need for any other physical installation or wearables. RoomMate™ offers patient privacy by design. Images are not stored, but all actions are logged. It’s a unique solution for looking after patients without intruding on their personal space.

Market Outlook

According to Grand View Research (Patient Monitoring Devices Market Size & Share Report, 2030), the global patient monitoring devices market size was valued at $47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The growing number of chronic disorders, such as diabetes, stroke, and kidney disease, are driving the demand for patient monitoring devices. For instance, according to the World Health Organization (WHO), about 422 million people globally have diabetes. Likewise, the number of asthma and chronic obstructive pulmonary disease patients (COPD) is increasing rapidly.

According to the WHO, around 235 million people suffer from asthma. As a result, peak flow meters, which are used to gauge respiration rate, are increasingly used. The market for patient monitoring devices is driven by the simplicity with which it is handled, transported, and remotely accessible. Major market players are engaging in a variety of tactics to expand the industry, including partnerships, cooperation, innovation, launches, and mergers.

During the COVID-19 outbreak, social segregation and quarantining procedures were put into place worldwide. Many people avoided regular hospital visits as a result. Many people now need routine home temperature and oxygen level monitoring to maintain track of their health, thereby demanding monitoring devices at home.

Various government programs are supporting the pandemic outbreak. The FDA has granted Emergency Use Authorizations (EUAs) for a few wearables and patient monitoring devices to improve access to medicines, monitor patients more closely, and lessen the risk of SARS-CoV-2 exposure to medical professionals during the COVID-19 pandemic.

The growing popularity of wearable and remote patient monitoring devices is another factor fueling the market’s expansion. By fusing clinical symptomology with vital indicators, wearable technology helps in the diagnosis of many chronic diseases. Thus, there has been a dramatic rise in the usage of wearable technology to combat COVID-19.

The wearable medical device market is anticipated to reach $174.48 Billion by 2030, expanding at a 27.1% CAGR during the forecast period (2022-2030), according to Market Research Future.

MetAlert identifies the total addressable market for its wearable patient monitoring tech for those with Alzheimer’s, dementia, and autism at more than 34 million potential patients in North America, Europe, South Africa, and Asia.

Management Team

Patrick E. Bertagna is Founder, CEO and Chairman at MetAlert. He began his career in apparel sales in 1983 and was promoted to national sales manager within two years. In 1986, he founded his first company importing apparel from Europe and selling to U.S. retailers from JCPenney to Neiman Marcus. He has founded several technology and apparel companies, including MetAlert in 2002, which he took public in 2008. He attended Cal State University Northridge with a business major and a psychology minor.

Louis Rosenbaum is COO of MetAlert. He co-founded Global Trek Xploration and was an initial investor in MetAlert. He has successfully started companies in multiple industries, including apparel, environmental services, and the music industry, achieving annual revenues in the multi-millions of dollars. He previously was president of Elements, a women’s apparel company, and of Advanced Environmental Services.

Alex McKean is CFO at MetAlert. He is also the CFO of Encore Brands Inc., a position he has held since 2009. He has held positions as Controller and VP of Finance at 24:7 Film and, Director of FP&A/SVP at Franchise Mortgage Acceptance Company, Corporate Accounting Manager/Treasurer of Polygram Filmed Entertainment and Assistant Treasurer/Controller for State Street Bank. He holds an International MBA from Thunderbird School of Global Management and undergraduate degrees in business and political science from Trinity University.

MetAlert Inc. (OTC: MLRT), closed Wednesday's trading session at $0.39, up 21.875%, on 127,199 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.06/$1.00.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

Cannabis policing has been an extremely controversial issue inAmerican history. While the war on drugs was ostensibly launched to cripple the criminal organizations behind the illicit drug trade, Black and Brown communities weredisproportionately affected by the antidrug campaign. Decadeslater, the drug war has decimated marginalized communities for minor drug charges and has long been declared an unmitigated failure. Even though the move to legalize cannabis across the country hasbeen praised by criminal and racial justice activists, the cannabisreform movement hasn’t received everyone’s support. The White Houserecently issued its annual drug enforcement report to Congress and highlighted several concerns that law enforcementhas regarding America’s growing state-level cannabis industry. Forinstance, the report outlined police concerns about burglaries and robberies in states with legal cannabis markets. Although cannabis is now legal in more than 30 states, it remains a controlled substance at the federal level. This haslargely prevented the state-legal cannabis industry from accessing crucial financial services, such as banking and cashless payment systems, forcing it to operate on amostly cash-only basis. As more companies such as India Globalization Capital Inc. (NYSE American: IGC) move toward medicalizing cannabis compounds, the discussion onthis plant will broaden as growing numbers of people seekFDA-approved treatments made from this divisive substance.

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Wednesday's trading session at $0.3643, up 4.8949%, on 134,692 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2785/$1.16.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Report notes that the global direct-selling establishments marketis expected to close the year out at a compound annual growth rate(“CAGR”) of 3.8%

The need for additional income opportunities has been a drivingfactor in the direct-selling establishments market

SHRG is committed to stay ahead of marketplace trends, fulfillneeds, create sustainable enterprise growth and consistentlyincrease shareholder value

In a market forecast to grow an estimated $20 billion this yearalone (, Sharing Services Global (OTCQB: SHRG) distinguishes itself in the direct-sales space by focusing on amission to increase shareholder value by adhering to standards ofexcellence that optimize the value of the people involved, supplychain, and channel of distribution, achieving optimal customersatisfaction through every subsidiary and partnership interest (

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

469.304.9400 x 201

Sharing Services Global Corporation (SHRG), closed the day's trading session at $1.01, up 23.17%, on 276,351 volume with 217 trades. The average volume for the last 3 months is 279,074 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

  • The growing perception is that cannabis companies investing inreal estate raise the value of the area in which they invest
  • A 2020 study conducted in states where medicinal andrecreational cannabis is legal found that 35-36% of respondentssaw an increase in demand for warehouses, 23% for storefronts,and up to 28% for land
  • The global legal cannabis market was valued at $17.8 billion in2021 and is expected to reach $134.4 billion by 2030
  • REZYFi is leveraging its corporate strengths through twowholly-owned subsidiaries – REZYFi Lending and ResMac Inc. –offering a diversified approach to cannabis and real estatefinancing that traditional banks are reticent to offer

Cannabis and real estate have a unique relationship. The growingperception on the market is that cannabis companies investing inreal estate raise the value of the area they invest in. Threestrong arguments support the perception – abandoned buildings aregaining new life when rehabilitated by cannabis businesses,entrepreneurs are investing in the cannabis market as an asset thatdoes not depreciate over time, and new jobs are increasingresidential home sales. In a 2020 study conducted in states wherecannabis for medicinal and recreational purposes is legal, 35 to36% of respondents noted an increase in demand for warehouses, 23%for storefronts, and up to 28% for land ( At the forefront of cannabis and real estate is REZYFi, a growth mortgage origination and specialized financing companyin the United States. REZYFi originates, structures, and invests infirst mortgage loans and alternative structured financing securedby commercial real estate properties. The company’s target marketincludes licensed and permitted cannabis companies, owners of realestate who lease to cannabis companies, and companies andindividual homeowners seeking a variety of real estate-relatedfirst and additional mortgage-based financing.

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.


REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.

Recent News


GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

• Energy costs are surging across America, driven by overreliance onnatural gas; this dominant fuel source for both home heating andelectricity generation has soared in price

• More and more states across the country are starting to push forrenewable energy adoption as benefits, both environmental andeconomic, are becoming apparent

• As the country’s unsustainable dependence on gas brings another hitto consumers’ budget, companies like GeoSolar works to offer abetter path forward with solutions designed to protect both theenvironment and consumers’ wallets

Americans are looking to take their green effort to a new levelwith sustainable living as fossil fuel-induced climate change hasworsened the risk of extreme weather events, increasing them infrequency, intensity, and scale. Coupled with energy priceincreases due to heightened international uncertainties, ithighlights the need for a shift from our reliance on energy fromfossil fuels. In an environment like this, companies like GeoSolar Technologies (“GST”), a Colorado-based climate technology Company, stand tobenefit as rising awareness of climate change is accompanied by theincreasing understanding that overreliance on fossil fuels can havea detrimental economic impact on consumers through high energycosts.

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

In April 2021, New York legalized recreational cannabis sales for people aged 21 and older, becoming the 15th state in thecountry to approve adult-use cannabis sales. Eligible New Yorkerswould now be able to possess up to three ounces of cannabis or 24grams of concentrates with no legal repercussions. While the legislation didn’t outline a specific schedule for recreational sales, theywere expected to begin sometime in 2022. Lawmakers behind the billand reform advocates predicted that the move to legalize adult-usemarijuana in New York could prove to be extremely lucrative,creating a market worth an estimated $4.2 billion and surpassingmost other states with recreational markets. An estimated 40% ofthe tax revenue generated from recreational cannabis sales in NewYork would be allocated to Black and Brown communities that had been disproportionately affected by the war on drugs. Asthe legal production of adult-use cannabis grows, there is likelyto be a bigger market for indoor cultivation equipment, such asthat made by Advanced Container Technologies Inc. (OTC: ACTX), as players compete to carve out for themselves a segment of thisnew market.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.


Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.


ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Wednesday's trading session at $0.4, even for the day, on 70 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2005/$1.40.

Recent News

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Arizona Metals (TSX: AMC) (OTCQX: AZMCF), a mineral exploration company focused on advancing precious andbase metal deposits, has commenced its phase 3 expansion drillprogram in the flagship Kay Mine Project. Thecopper-gold-zinc-silver asset is located in Yavapai County on acombination of private land and BLM claims. “Arizona Metals pridesitself on having unique features that distinguish the company inthe market. The first quality is the Kay Mine Project’s grade andwidth. Next, it’s the mine’s polymetallic nature, which, at thesegrades and widths, gives the potential for significant metal outputwith a low footprint. This also implies lower capital and operatingcosts. Finally, it’s the scale… Although most of the gold andcopper-rich volcanogenic massive sulfide (‘VMS’) were mined out inthe last 100 years, the company claims that the Kay Mine isdifferent,” a recent article reads. “What we see as the realpotential is the scale. We have high grades, large widths, now youwant tons. We think Kay Mine alone has great tonnage potential. Onour property, we have 16 targets outside of the Kay Mine, but allwithin a 1.5km radius that have never been drill tested,” MarcPais, Arizona Metals’ president and CEO, is quoted as saying. “KayMine is unique in the fact that it was basically abandoned for 40years until 2019 when we acquired it. During that time, no work wasdone...”

To view the full article, visit

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.


Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Vision Energy Corp. (OTCQX: AZMCF), closed Wednesday's trading session at $3.3285, off by 0.344311%, on 50,995 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.30/$5.60.

Recent News

Aditxt Inc. (NASDAQ: ADTX)

The QualityStocks Daily Newsletter would like to spotlight Aditxt Inc. (NASDAQ: ADTX).

Aditxt (NASDAQ: ADTX), a biotech innovation company, is developing and commercializingtechnologies with a focus on monitoring and modulating, mapping andreprogramming the immune system, designing technologies to providea personalized immune profile. “In late October 2022, Aditxtannounced the creation of its Adimune(TM) program. At the sametime, Aditxt announced that Adimune initiated the GMP manufacturingof drug candidate ADI(TM)-100 for purposes of initiating humantrials. The trial will be performed in autoimmune diseases, withpsoriasis as the first indication to be studied. Adimune’s nucleicacid-based technology, ADI(TM), has shown in preclinical studiesthe ability to restore/induce immune tolerance in anantigen-specific way without impairing the immune response to fightinfections and cancer. According to Amro Albanna, co-founder,chairman and CEO of Aditxt, the company’s vision is dedicated to anew era of precision medicine through individual immune monitoringand modulation,” reads a recent article. “We are laser-focused onadvancing each of our innovation programs toward commercialization.Adimune’s initiation of ADI-100 manufacturing is measurableprogress of Adimune toward our 2023 strategic goals,” Albanna isquoted saying.

To view the full article, visit

Aditxt Inc. (NASDAQ: ADTX) is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. Aditxt’s immune mapping technologies are designed to provide a personalized immune profile. Aditxt’s immune reprogramming technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.

As further discussed below, the company’s first commercial product is an immune mapping technology, AditxtScore™, which is designed to provide a personalized profile of the immune system.

The company’s preclinical immune reprogramming technology, Apoptotic DNA Immunotherapy™ (“ADi™”), aims to retrain the immune system to induce tolerance, with the goal of addressing vast unmet needs in transplanted organ rejection, autoimmune diseases, and allergies. The company is developing specific ADi™ products for psoriasis, type 1 diabetes, and skin grafting.

Headquartered in Richmond, Virginia, Aditxt also operates locations in Silicon Valley and New York.


AditxtScore™ is a proprietary platform designed to provide a personalized, comprehensive profile of an individual’s immune system. The underlying technology, licensed from Stanford University through an exclusive worldwide agreement, offers a highly sensitive and accurate method of detecting and quantifying cellular responses, allowing greater specificity, quantification, and amplification of both clinical and commercial opportunities.

The company’s first commercial application of the platform, AditxtScore™ for COVID-19, delivers timely reports on vulnerability and immune status relating to SARS-CoV-2 and its known variants, giving consumers and physicians the data needed to make informed health decisions. Potential future applications will offer early detection of an array of conditions, including diabetes, cardio-metabolic maladies and hormonal imbalances.

Aditxt’s AditxtScore™ immune monitoring center in Richmond, Virginia, is operational and designed to support the anticipated increased demand for AditxtScore™ as well as related products and services. The company is currently scaling its capabilities at this location, with a goal of processing up to 10 million immune system tests/reports annually.


ADi™ is Aditxt’s immune reprogramming platform addressing disease-causing immune responses while maintaining the immune system’s ability to combat pathogenic infection. The company is commercializing a nucleic acid-based technology called Apoptotic DNA Immunotherapy™ (ADi™) which utilizes a novel approach that mimics the way our bodies naturally induce tolerance to our own tissues (therapeutically induced immune tolerance). Aditxt believes its ADi™ technology platform can be engineered to address a wide variety of indications.

Aditxt is currently developing ADi™ products for psoriasis, type 1 diabetes and skin grafting.

Currently, immuno-tolerance is achievable through chimerism and cell-based therapy, but there is a clinical need for a more practical and cost-effective approach which:

  • Can be made into a product
  • Does not require additional hospitalization
  • Is simple to produce and ship

Preclinical studies have demonstrated that ADi™ treatment significantly and substantially prolongs graft survival, in addition to successfully “reversing” other established immune-mediated inflammatory processes. ADi™ treatment is not expected to require hospitalization, instead being delivered as an injection in minute amounts into the skin.

IP Portfolio

Both AditxtScore™ and ADi™ are supported by a strong IP portfolio.

AditxtScore™, built upon initial technology invented, licensed from and used at Stanford University, is protected by U.S. patents encompassing methods, systems, and kits for detection and measurement of specific immune responses.

ADi™ technology is protected by seven patent families, including:

  • 8 U.S. patents
  • 4 pending U.S. patent applications
  • 86 foreign patents and 14 pending foreign patent applications spanning the EU, Australia, Canada, Japan, China, India and Hong Kong

These patents are broadly categorized into three groups:

  • Autoimmune diseases and Type 1 Diabetes
  • Organ transplantation and a method of producing plasmid DNA to prevent immune activation
  • Composition of matter for a tolerance delivery system for antigens of interest

Aditxt also possesses and/or in-licenses substantial know-how and trade secrets relating to the development and commercialization of its product candidates, including related manufacturing processes and technologies.

Market Overview

The potential market opportunities presented by immune monitoring and reprogramming are extensive, particularly as Aditxt continues to evaluate additional applications for the platforms.

The company’s initial focus on organ transplantation and related autoimmune response provides some insight into the potential of its approach. According to BCC Research, the global organ and tissue transplantation and alternatives market is on course to reach $120.3 billion by 2024, recording a CAGR of 7.4% from 2019. Industry data suggest that approximately 50% of all transplanted organs are rejected within 10-12 years, further highlighting the critical need for a practical, cost-effective solution to harmful autoimmune responses.

Through its focus on the COVID-19 testing market with AditxtScore™, Aditxt demonstrated the wide-ranging potential of its portfolio. Fortune Business Insights estimated the global COVID-19 diagnostics market at $48.64 billion for 2022. While demand for COVID-19 diagnostics is expected to lessen in the coming years, Aditxt will be uniquely positioned to leverage its existing infrastructure stemming from these operations as the company works to advance broader applications for the AditxtScore™ platform.

Leadership Team

Amro Albanna is the Co-Founder, Chairman, and CEO of Aditxt. He has founded multiple startups to commercialize innovations in various industries, including healthcare, enterprise software, telecommunications, nano technology, consumer health, and biotech. Mr. Albanna has led numerous M&A and going-public transactions as a founder, co-founder, and senior executive.

Shahrokh Shabahang, D.D.S., MS, Ph.D., is the company’s Co-Founder, Chief Innovation Officer, and a member of its board. He brings to the team more than 20 years of experience in developing and commercializing life science technologies focused on product and clinical development in the fields of microbiology and immunology.

Corinne Pankovcin, CPA, MBA, is the President of Aditxt. Prior to joining Aditxt, Ms. Pankovcin served as CFO for several world class organizations, including Business Development Corporation of America, Blackrock Kelso Capital and AIG Capital Partners. In these roles, Ms. Pankovcin was responsible for executing portfolio investments and managing significant M&A transactions.

Thomas Farley is the Chief Financial Officer of Aditxt. From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant.

Rowena Albanna is the company’s Chief Operating Officer. Ms. Albanna has over two decades of experience in senior leadership roles for both technology startups and public companies. Ms. Albanna’s experience spans a wide variety of industries, including biotechnology, insect control, nanotechnology, consumer electronics, financials, telecommunications, e-commerce, online marketing, medical, and defense.

Matthew Shatzkes is the Chief Legal Officer and General Counsel of Aditxt. As a former partner at an AM Law 50 law firm, Mr. Shatzkes advised a wide variety of healthcare related entities, including biotech companies, on corporate, regulatory, and strategic business matters. Mr. Shatzkes will oversee all aspects of the legal functions at Aditxt, including, providing advice and counsel on governance, regulatory matters, strategic alliances, mergers and acquisitions, and commercial transactions.

Aditxt Inc. (NASDAQ: ADTX), closed Wednesday's trading session at $1.34, off by 2.1898%, on 174,855 volume. The average volume for the last 3 months is 173,108 and the stock's 52-week low/high is $1.00/$28.49.

Recent News

Correlate Infrastructure Partners Inc. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Infrastructure Partners Inc. (OTCQB: CIPI).

Correlate Infrastructure Partners Inc. is a distributed energysolutions company drawing on tech-enabled development, finance, andfulfillment resources, to support businesses that develop and rentout commercial building properties

Commercial real estate industry businesses served by CIPI are amonga large field of corporations working to improve theirenvironmental, social and governance (“ESG”) profiles in order toappeal to climate-conscious investors

ESG-conscious investment rose to a record $69.2 billion in 2021 andcontinues to weather “anti-woke” pushback efforts that have becomemore pronounced in recent months

Multinational investment bank JPMorgan Chase provided a good ofongoing climate consciousness when it announced 2030carbon-reduction targets for the oil and gas, electric power, andauto manufacturing sectors last year, and added similar goals forthe iron and steel, cement, and aviation sectors this month

Distributed energy solutions company Correlate Infrastructure Partners (OTCQB: CIPI) is helping clients do more to improve their environmental, socialand governance (“ESG”) profiles as investors show a growinginterest generally in backing such efforts. In 2021, shareholdersdedicated a record $69.2 billion to ESG-weighted funds ( Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, works as aplatform for helping businesses in the commercial real estateindustry acquire solutions for solar, cogeneration, energy storage,and electric vehicle infrastructure to improve their environmental,social and governance (“ESG”) position. “In working with globalstored energy solutions leader EnerSys(R) (NYSE: ENS) on improving its carbon footprint at its Pennsylvaniaheadquarters, Correlate Infrastructure Partners is reporting‘officially one of the largest behind-the-meter solar installationsin the United States.’ … EnerSys supports the global community withproducts to meet the need for efficient and affordable distributionof goods, grid reliability, telecommunications, and electrificationof customers’ previously fossil fuel-driven operations. But theCorrelate solar energy installation project, totaling 3.8megawatts, shows EnerSys’ commitment to managing its ownenvironmental impact,” a recent article reads. “We’re proud to beworking with EnerSys to further advance solar development in theCommonwealth and support their commitment to long-termsustainability as an industry leader,” Correlate CEO Todd Michaelsis quoted as saying. “This partnership and project bring together adecade of our team’s vision, whereby we are both supporting acorporate renewables program and helping decarbonize the supplychain with a global market leader.” To view the full article,visit

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment solutions for the commercial real estate industry. The company believes scaling distributed clean energy solutions is critical in mitigating the effects of climate change. CIPI is at the forefront in creating an industry-leading energy solution and financing platform for the commercial and industrial sector. The company sees tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale.

The opportunity exists to remove friction between today’s legacy finance process and the needed clean-energy upgrades developed within the company’s program technologies. For the U.S. to reach its 2050 carbon goals, 200,000 commercial buildings must be retrofitted every year until that date. That represents approximately a 5-10x increase over the 2022 industry process run rate.

CIPI announced completion of its acquisition of 100% of the equity of Correlate Inc. and Loyal Enterprises LLC dba Solar Site Design on December 28, 2021. The company notes these acquisitions occurred at a key inflection point of its growth. CIPI currently enjoys channel and sales partnerships with Fortune 250 companies and a strong, proven industry network.

The company’s transparent, leading-edge model changes value delivery for both facility owners and proven solution providers seeking scale. CIPI believes its rapid growth is due to industry demand for actionable, cashflow positive energy programs and the underlying carbon reduction mandates taking effect globally.

CIPI has filed with the SEC for a name change to Correlate Infrastructure Partners Inc., which will more closely reflect its new platform and growth focus. The company has been aggressively moving to rebrand, with efforts including a revised website, investor presentation materials and an investor relations awareness campaign. The company’s shares will continue to trade on the OTCQB Venture Market under the current ‘CIPI’ ticker symbol until changes are approved.


Correlate, founded in 2015, is a portfolio-scale development and finance platform offering commercial and industrial facilities access to clean electrification solutions focused on locally-sited solar, energy storage, EV infrastructure, and intelligent efficiency measures. Its unique data-driven approach is powered by proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network to help building owners profit from fully funded, turnkey decarbonization and facility health programs. The platform is designed for commercial and industrial real estate owners seeking to significantly improve net operating income while meeting carbon reduction goals. The platform provides energy programs for commercial property portfolios and requires no upfront capital. Client organizations reduce their risk and generate more profits by leveraging Correlate’s unique payment programs to put more cash in the bank. Deploying Correlate’s strategic energy programs and energy management systems allows property-owning organizations to complete big energy changes across their portfolios.

Solar Site Design, founded in 2013, is a U.S. Department of Energy Sunshot Catalyst winner that provides customer acquisition and project development tools for the commercial solar industry. Its commercial marketplace platform connects highly qualified project opportunities to leading solar construction companies nationwide. The Solar Site Design platform gives commercial and industrial property owners access to the best price for a commercial solar system. Commercial solar analysts provide property owners a site assessment and working project proposal. Solar Site Design’s team of solar engineers finalize the design while approved financing providers help clients explore financing options for their projects. Then, approved contractors in Solar Site Design’s Marketplace bid on the projects, ensuring commercial and industrial property owners get the best estimates for their projects. Solar Site Design’s marketplace process promotes transparency and fair pricing. Its team of experts has nearly 20 years of experience in the solar industry. Only reputable, experienced, certified (NABCEP), licensed, bonded and insured contractors are accepted into the Solar Site Design Marketplace.

Market Outlook

CIPI is in a rapidly growing market with a unique offering to address a total market of more than 5.9 million commercial buildings in the United States, according to the U.S. Energy Information Administration. Currently, the company’s wholly owned subsidiaries, Correlate and the Solar Site Design, have an opportunity pipeline of over $100 million in commercial projects with more than $20 million in awarded backlog. According to the Rocky Mountain Institute, portfolio energy optimization is a $290 billion market in the United States driving deep financial savings and energy efficiency across the commercial sector.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon, and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings. Yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which has very different needs than traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue known as the “split incentive”, unlocking the majority of the addressable market.

Management Team

CIPI has in place a nationally recognized management team that has been active in the energy market since 2005.

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

David Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jason Loyet is VP of Commercial Sales of Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Deke Welling is Head of Project Development and Fulfillment Services at Correlate Inc. He has over 19 years’ experience in the energy industry with an emphasis on renewables and energy efficiency over the past seven years. Prior to entering the renewables sector, Mr. Welling was the CEO of Welling Resources, an energy development company focused on the exploration of oil and natural gas reserves in the U.S. It was this experience that led him into the renewables sector and leading a charge for more sustainable resources. Additionally, Mr. Welling also served as the CEO of Circle L Solar Inc., a top 100 solar installer in the United States since 2016. Through his leadership, Circle L Solar experienced a growth rate of over 2,250% from 2016 to 2019, resulting in his company being listed on the Inc. 5000 list of the fastest growing private companies in the U.S. (Rank #176) and being named ‘Top Energy Company’ and ‘Entrepreneur of Year for the Energy Industry’ by the American Business Awards® in 2019 and again for ‘Entrepreneur of the Year’ in 2021.

Kevin Warren is Head of Construction and Development Engineering at Correlate Inc. He is a solar veteran with over 12 years of experience in the field. Prior to co-founding CLS, Mr. Warren was the owner of Beacon Consulting and has originated, consulted, designed and/or engineered over 122 MW of PV installations ranging from small commercial to utility scale projects throughout Texas, California, Colorado and North Carolina. He holds a Photovoltaic Technical Sales Professional Certification from the North American Board of Certified Energy Practitioners and certifications from Solar Energy International in PV Installation, PV Technical Sales, PV battery-based design, PV design and engineering, and PV operations and maintenance. Along with PV expertise, Mr. Warren is a LEED Green Building Associate, a certified building analyst from the Building Performance Institute, a Certified Renewable Energy Professional from the Association of Energy Engineers and holds a designation in High-Performance Sustainable Buildings from the BOMI Institute. He studied Electrical Engineering at the University of Texas at Arlington.

Tom Kunhardt is Director of Customer Success at Correlate. He previously held a similar position at Clean.Tech and was Corporate Trainer, Learning & Development, at NRG Energy. He has 15 years of experience in the solar and clean energy industries helping homeowners and businesses find solutions to their energy needs. He holds a bachelor’s degree from the University of Massachusetts.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), closed Wednesday's trading session at $1.06, off by 1.8519%, on 100 volume. The average volume for the last 3 months is 100 and the stock's 52-week low/high is $0.71/$3.25.

Recent News

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F)

The QualityStocks Daily Newsletter would like to spotlight Hillcrest Energy Technologies Ltd. (OTCQB: HLRTF).

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a clean technology company developing transformative powerconversion technologies and control system solutions fornext-generation electrical systems, today provided an update on itsanticipated development and commercialization targets for 2023.“2023 marks a transitional year in our story, with the focusshifting to the application of our core ZVS inverter technologyinto new products and end uses. We are expanding our focus toinclude grid-tied applications while maintaining and growingrelationships in the automotive sector,” said Hillcrest CEO DonCurrie. “Our near-term objective is to engage up to two additionalEV customers and ramp up new customer agreements for our grid-tiedrenewable energy generation and Energy Storage System (‘ESS’)segments. Combined, we believe these development andcommercialization activities will position us well to securecommitments for commercial revenues by the end of the year. … FromEV to grid, IP progress to customer engagements, Hillcrest islooking forward to a promising 2023.”

To view the full press release, visit

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) is a clean technology company based in Vancouver, British Columbia, engaged in developing high-value, high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems.

From concept to commercialization, Hillcrest invests in the development of energy solutions that power a more sustainable and electrified future. Hillcrest power inverter technology helps produce efficiencies in electrification and maximize the performance of electric systems, including electric vehicles (EV), motors and generators.

The company offers a flexible, single-inverter architecture that can be applied at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of an EV, to provide full-cycle efficiency and performance improvements.

As momentum to electrify and decarbonize energy systems accelerates, Hillcrest believes the power inverter is increasingly emerging as a key component. While system cohorts such as battery packs, PV panels and electric motors are often in the spotlight, the inverter holds the key to unlocking efficiency and performance improvements.

Hillcrest power inverter technology is:

  • REVOLUTIONARY: high-efficiency inverter technology has the potential to revolutionize how motors respond and how efficiency is gained.
  • AGILE: able to deliver and deploy high-efficiency inverter solutions purpose-designed to meet specific customer needs.
  • INNOVATIVE: technology-forward, clean-energy experts who are focused on advancing and optimizing efficient alternative energy use across all electric vehicle and charging platforms.
  • A MARKET LEADER: a next-generation technology provider to the automotive industry’s top suppliers and manufacturers.

Technology & Applications

Hillcrest’s first application for its inverter technology – a 250 kW|800V Hillcrest SiC high efficiency traction inverter – is focused on the growing EV market. Hillcrest technology eliminates traditional design trade-offs faced across the power industry – deploying higher switching frequencies has historically meant a greater increase in losses, lower system efficiency and higher heat. Through a combination of hardware and software expertise, Hillcrest enables power applications to leverage higher switching frequencies AND

  • Realize improved power system performance and reliability
  • Operate at higher power levels without compromising efficiency

The expected benefits of Hillcrest’s traction inverter have been confirmed via testing and shared in a technical white paper, published in April 2022, that confirmed the following results:

  • Significant efficiency gains – 99%-plus inverter efficiency
  • Increased power density targeting 50kW/L+
  • Significantly increased motor efficiency
  • Lower stress on mechanical and electrical parts, enhancing reliability
  • Improved thermal management

Hillcrest has also filed a patent for an enhanced powertrain solution that offers the potential to simplify EV charging and redefine how the industry envisions charging infrastructure. The company believes the most exciting benefit of the enhanced powertrain solution is the ability to eliminate the onboard charger and booster from an EV, as well as faster, anywhere charging including direct DC, wireless, and bidirectional charging across current and future power levels. Hillcrest sees this as a true EV charging game changer.

The company’s technology applies to nearly every clean energy industry segment:

  • Wind power – an inverter is deployed at a wind turbine generator to convert the AC output, with at least one additional inverter used to deliver the power to the grid/battery.
  • Solar power – an inverter is used to convert the DC output from the photovoltaic panels into the AC power that flows to the grid/battery/home.
  • Energy storage – an inverter is deployed to convert the DC output from the storage system or batteries to the AC power that flows to the grid/home/EV.
  • EV fast chargers – an inverter converts the AC input from the grid/storage system to the DC output needed to charge an EV’s battery.

Market Outlook

According to an April 2022 market analysis by Vantage Market Research (VMR), the global power inverter market is expected to reach a value of $95 billion by 2028, driven by increasing demand for EVs, energy generating wind turbines and solar-powered photovoltaic systems. That jump is forecast from an estimated $70.5 billion market value in 2021 and represents a compound annual growth rate of more than 5%.

According to the VMR report, many governments in countries around the world are supporting alternative options for efficient and nonpolluting energy generation. This has boosted demand for wind energy and solar energy systems. Hillcrest is aiming to capture a share of this future market growth across nearly every segment of the clean energy industry.

Management Team

Don Currie is the founding CEO of Hillcrest Energy Technologies. He has led the company’s successful transition from fossil fuels into clean energy technologies. Earlier in his career, he held various senior level positions, including director, officer and vice president of corporate communications with Enhanced Oil Resources Inc., an oil and gas exploration and production company based in Houston. Prior to that, he worked in other private and public ventures spanning the mining, gaming and technology sectors.

Jamie L. Hogue is the COO of Hillcrest. She brings more than two decades of progressive policy leadership, economic analysis and organizational development experience to Hillcrest. She builds collaborative processes and solutions that drive growing organizations toward a more resilient future. She previously served as the director of operations for Arizona State University’s Ten Across initiative – a compelling observatory positioned on the front lines of economic, social and climate change. She earned a master’s degree in public administration and a bachelor’s degree in economics from Arizona State University.

Ari Berger is Chief Technology Officer at Hillcrest. He brings over a decade of commercial experience with a track record of deploying new electrification technologies and go-to-market strategies. In 2015, he founded NIG Systems Ltd. in Israel, which specializes in custom high performance control systems design. Prior to this, he previously worked for Bental Industries, a leading motor manufacturer. He holds a master’s degree in system control engineering from the Technion – Israel Institute of Technology.

Raj Clair is CFO at Hillcrest. She is a CPA who began her career at Deloitte and has served in advanced finance positions in the energy and resources sector. She has been responsible for reporting, audits and internal controls, as well as working on budgeting and forecasting. She has worked with various publicly listed companies, including SEC registrants, and has both Canadian and U.S. experience. She holds a bachelor’s degree in accounting from Simon Fraser University.

Hillcrest Energy Technologies Ltd. (NASDAQ: HLRTF), closed Wednesday's trading session at $0.0675, off by 7.4709%, on 150,140 volume. The average volume for the last 3 months is 150,140 and the stock's 52-week low/high is $0.0584/$0.1512.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.